New Hope Liuhe-backed Dong Pinhui has collected $14.3m to drive geographical and product expansion.

Each Friday, the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Mayo Clinic Ventures pumped in a share of the proceeds for Cadence Neuroscience, which is working on biomarker-powered neuromodulation therapies for drug resistant-focal epilepsy.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Astellas has re-invested in Coda Biotherapeutics, which is working on therapies for conditions such as focal epilepsy and chronic neuropathic pain.

The corporate joined Radical Ventures and unnamed backers to invest in Untether AI, with the funding going towards the AI chip manufacturer’s growth strategy.

Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.

Goldman Sachs has backed lease accounting software company LeaseQuery, in what appears to be the lease accounting software provider's first round.

UCSD-founded Shape Therapeutics has collected series A cash from NEA and CureDuchenne Ventures to progress its RNA gene editing technology.

Building on the work of University of Sydney researchers, Kira Biotech has raised $13.6m from investors including IP Group to progress antibodies for autoimmune diseases.